Navigation Links
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
Date:5/8/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2010)... OR ACCOUNTING TREATMENT , ... , , ... ... ... March 12 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) today announced that it will restate its 2008 financial statements contained in its Annual Report ...
(Date:3/11/2010)... Stem Cell Assurance, Inc. ... announce the inclusion of one of the Cleveland Clinic,s ... M.D., F.A.C.S.  Dr. Ross will officially take up Vice ...  Stem Cell Assurance welcomes his appointment to strengthen operations ... and cosmetic procedures and cell banking to individual clients. ...
(Date:3/11/2010)... - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, today ... Network (UHN) and The Hospital for Sick Children (SickKids) in Toronto, Ontario ... areas of hematopoietic stem cell transplantation and cancer. , ... ... ...
(Date:3/10/2010)... The domestication of animals and plants is the ... genetic transformation of wild species has occurred as ... for breeding purposes. In the current issue of ... researchers at Uppsala University has revealed some of ... domestic chicken. , The domestic chicken has in ...
Breaking Biology Technology:Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 2Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 3Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 4Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 5Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 6Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 7Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 8Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 9Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 10Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 2Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 3Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 4Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 2Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 3Scientific breakthrough in genetic studies of animal domestication 2
... First new treatment option in more than 40 ... one monthDEERFIELD, Ill., and OSAKA, Japan, Feb. 13 ... subsidiary, Takeda Pharmaceuticals North America, Inc., announced today ... (FDA) has approved ULORIC(R) (febuxostat) 40 mg and ...
... Crystal Research Associates, LLC,announced today that it has ... Life Sciences Inc. (BNC: TSX). The full,68-page report ... Bioniche Life Sciences Inc. ... that aims to improve the quality of life ...
... in Second Quarter,TORONTO, Feb. 13 /PRNewswire-FirstCall/ - Microbix ... challenging year for the biopharmaceutical industry, it has ... the ultimate goal of sustained profitability. The Company ... December 31, 2008. , In a news release ...
Other Biology Technology:FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout 2FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout 3FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout 4Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. 3Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 2Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 3Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 4
(Date:3/14/2010)... quickly becoming the "go-to" remedy for treating a wide ... evidence from a Wake Forest University School of Medicine ... low levels may have different effects based on patient ... do harm. , The study is the first ... large arteries, a measure of atherosclerosis or "hardening of ...
(Date:3/14/2010)... appear to be wired to keep seeking a reward ... The research uncovers the role of the brain,s reward ... study for understanding what drives these individuals. , ... it relates to behavior," Dr. Francis S. Collins, director ... may help us find new ways to intervene before ...
(Date:3/12/2010)... (March 12, 2010) Calculations are fine, but seeing ... by Rice University students who decided to put to ... , In 1908, the German physicist Gustav Mie ... describe the interaction of electromagnetic waves with a spherical ... since for researchers seeking to quantify how nanoscale plasmonic ...
Breaking Biology News(10 mins):Vitamin D levels have different effects on atherosclerosis in blacks and whites 2Vitamin D levels have different effects on atherosclerosis in blacks and whites 3Psychopaths' brains wired to seek rewards, no matter the consequences 2Psychopaths' brains wired to seek rewards, no matter the consequences 3Look at Mie! 2Luth Researchs IndicatorEDG 28TM 29 Study Finds Americans Hopes of Achieving Their Dreams Are Fading 66290 1Luth Researchs IndicatorEDG 28TM 29 Study Finds Americans Hopes of Achieving Their Dreams Are Fading 66290 2Luth Researchs IndicatorEDG 28TM 29 Study Finds Americans Hopes of Achieving Their Dreams Are Fading 66290 3Luth Researchs IndicatorEDG 28TM 29 Study Finds Americans Hopes of Achieving Their Dreams Are Fading 66290 4Avrio Receives Drug Manufacturing License and Medical Device Manufacturing License from the California Food and Drug Branch 7765 1Avrio Receives Drug Manufacturing License and Medical Device Manufacturing License from the California Food and Drug Branch 7765 2Avrio Receives Drug Manufacturing License and Medical Device Manufacturing License from the California Food and Drug Branch 7765 3Defining the Perfect Brows Just Got Easier 66289 1Defining the Perfect Brows Just Got Easier 66289 2
... just solved the structure of the first mammalian GRP94 protein ... cancers. His work is being published today in a ... , Gewirths study confirms his 2001 hypothesis that ... as the better known HSP90 proteins. As ligand-regulated chaperones ...
... of contemporary humans or an evolutionary side branch that ... questions in human evolution as scientists explore the relationship ... today. Two recent papers describing the sequencing of Neanderthal ... answering this question [1, 2]. However, the two studies ...
... rage in environmental policy. They are already used internationally ... group of economists and ecologists from the UK, the ... whether such schemes could work for wildlife too. So ... landscapes like farmland. , The European Commission expressed an ...
Other Biology News:First high-res 3D structures of mammalian HSP90 protein solved 2First high-res 3D structures of mammalian HSP90 protein solved 3Buying and selling habitats to help wildlife 2
... Engine instrument is the cycler that ... thermal uniformity and swappable blocks ensure ... This rugged machine is more ... platform for new features and upgrades ...
... Multiple Species Tissue Array (MSTA) slides were designed ... and tissues from multiple species. Tissue slices ... MSTA slide which can then be treated as ... or in situ hybridization. This ...
... Clear yellow solution. ... 0.01% thimerosal, and other ... filtered. Diluent formulated to ... peroxidase antibody conjugates at ...
... WinMelt software is used to ... any DNA sequence up to ... optimizing placement of primers and ... by denaturing gradient gel electrophoresis ...
Biology Products: